⏳ Fetching live dividend data...
Home › Calculator › NTEC Dividend Calculator 2026
Intec Pharma Ltd · NASDAQ
Price: $9.63 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in NTEC → $66.0K in 10 years · $945.81/month
Intec Pharma Ltd. is a clinical-stage biopharmaceutical company, founded in 2000 and headquartered in Jerusalem, Israel. The company specializes in developing therapeutic drugs using its proprietary Accordion Pill platform technology, which was also developed in Israel. This innovative oral drug delivery system is engineered to boost the effectiveness and safety of both existing medications and those under development by employing a distinct mechanism that ensures gastric retention and a controlled release of the drug within the stomach. The company's most advanced product candidate is Accordion Pill Carbidopa/Levodopa, currently undergoing a Phase III clinical trial to manage Parkinson's disease symptoms in patients with advanced forms of the illness. Intec Pharma's pipeline also features Accordion Pill Zaleplon, which is in Phase III clinical trials as a treatment for inducing and maintaining sleep for individuals experiencing insomnia. Additionally, a product candidate designed to prevent and treat gastroduodenal and small bowel ulcers caused by Nonsteroidal Anti-Inflammatory Drugs has successfully completed its Phase I clinical trial. The company is further developing AP-CBD/THC, AP-THC, and AP-CBD, cannabinoid-based product candidates containing Cannabidiol and 9-Tetrahydrocannabinol, aimed at alleviating various pain conditions. Intec Pharma Ltd. has also entered into a research collaboration agreement with Merck to investigate the potential uses of its Accordion Pill platform in Merck's development initiatives. Originally known as Intec Pharmaceuticals (2000) Ltd., the company officially changed its name to Intec Pharma Ltd. in March 2004.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NTEC position with:
Real after-tax yield depends on where you live and how you hold NTEC.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 20.77% | 17.97% | $2,077 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 17.65% | 14.85% | $1,765 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 16.62% | 13.82% | $1,662 / yr |
| 🇬🇧 UK ISA | 0% | 20.77% | 17.97% | $2,077 / yr |
| 🇬🇧 UK Taxable | 8.75% | 18.95% | 16.15% | $1,895 / yr |
| 🇨🇦 TFSA | 0% | 20.77% | 17.97% | $2,077 / yr |
| 🇨🇦 CA Taxable | 25% | 15.58% | 12.78% | $1,558 / yr |
| 🇦🇺 Super (pension) | 15% | 17.65% | 14.85% | $1,765 / yr |
| 🇦🇺 AU Taxable | 30% | 14.54% | 11.74% | $1,454 / yr |
| 🇩🇪 DE Taxable | 26.375% | 15.29% | 12.49% | $1,529 / yr |
| 🇫🇷 FR Taxable | 30% | 14.54% | 11.74% | $1,454 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
NTEC pays quarterly — 4 times per year. Next ex-div: TBD.
How NTEC compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NTEC sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Other | 2021-07-23 | 500 | $24.60 | $12.3K | ||
| Other | 2021-07-23 | 250 | $355.20 | $88.8K | ||
| Other | 2021-07-23 | 250 | $388.60 | $97.2K | ||
| Other | 2021-07-23 | 281 | $480.00 | $134.9K | ||
| Other | 2021-07-23 | 250 | $388.60 | $97.2K | ||
| Other | 2021-07-23 | 250 | $355.20 | $88.8K | ||
| Other | 2021-07-23 | 500 | $24.60 | $12.3K | ||
| Other | 2021-07-23 | 250 | $355.20 | $88.8K | ||
| Other | 2021-07-23 | 250 | $388.60 | $97.2K | ||
| Other | 2021-07-23 | 500 | $24.60 | $12.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NTEC dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Intec Pharma Ltd (NTEC) is currently trading at $9.63, trading near its 52-week low. The current dividend yield is 20.77% based on an annual payout of $2.00 per share.
Intec Pharma Ltd (NTEC) is a healthcare stock currently trading at $9.63 with a dividend yield of 20.77%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →